global leader, page-49

Thanks for the feedback Hesk, makes sense that Janssen have a couple of phylomers and are trying to pick the best one. If a deal of 4mil or more value were to materialise that would certainly move us up to the next division. Enumerate i think you are right when you talk about not unerestimating the technology. I think that is the biggest thing here, hopefully they become a one stop shop where clients turn up asking for a suitable phylomer, then pyc find verify and license a suitable phylomer for them, job done. Now that would be good and may be possible if the technology is good. That would be a far better use of their business model to do research for payment. No more 2 year deals, just find the suitable phylomer hopefully in a fraction of the time.